Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal antibody to VAPA (VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region within amino acids 29 and 122 of VAPA (Uniprot ID#Q9P0L0) |
Rabbit Polyclonal Trk B (Tyr515) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Trk B around the phosphorylation site of Tyrosine 515 (peptide seq 509-521aa: VIENPQY(p)FGITN) |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CB1 (isoform a) Antibody
| Applications | WB |
| Reactivities | Human, Mouse (Expected from sequence similarity: Rat, Dog, Cow) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-CB1 (isoform a) Antibody: Peptide with sequence SNDIQYEDIKGDMAS-C, from the N Terminus of the protein sequence according to NP_057167.2. |
Goat Polyclonal Antibody against Tafazzin
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1. |
Goat Polyclonal Antibody against NGFR
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-AKREEVEKLLNG, from the internal region of the protein sequence according to NP_002498.1. |
Goat Anti-Ramp1 (C-Term., mouse) Antibody
| Applications | WB |
| Reactivities | Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-DYQSKRTEGIV, from the C-Terminus of the protein sequence according to NP_058590.1; NP_848488.2. |
Rabbit Polyclonal LY6K Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | LY6K antibody was raised against an 18 amino acid synthetic peptide near the amino terminus of human LY6K. |
Phospho-IGF1R-Y1161 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A phospho specific peptide corresponding to residues surrounding Y1161 of human IGF1R |
| Modifications | Phospho-specific |
Phospho-KDR-Y1175 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A phospho specific peptide corresponding to residues surrounding Y1175 of human KDR |
| Modifications | Phospho-specific |
Rabbit Polyclonal Anti-CHRM1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein of human CHRM1 |
Rabbit polyclonal anti-COX IV antibody, Loading control
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Bovine, Primate, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to an internal region of the human COX4-1 protein (within residues 1-100). [Swiss-Prot# P13073] |
Goat Polyclonal Antibody against Caveolin 1
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-DELSEKQVYDAH, from the internal region of the protein sequence according to NP_001744.2. |
Goat Polyclonal Antibody against TUSC3
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence PQRQCSVCRQAN, from the internal region of the protein sequence according to NP_006756.2; NP_839952.1. |
Rabbit Polyclonal Disp2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Disp2 antibody was raised against a 19 amino acid peptide from near the carboxy terminus of human Disp2. |
Rabbit Polyclonal CLDN1 Antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | CLDN1 antibody was raised against a 20 amino acid synthetic peptide near the carboxy terminus of human CLDN1. The immunogen is located within the last 50 amino acids of CLDN1. |
Rabbit polyclonal Ret (Ab-905) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Ret around the phosphorylation site of tyrosine 905 (D-S-YP-V-K). |
Rabbit polyclonal ANKH Antibody (C-term)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This ANKH antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 464-492 amino acids from the C-terminal region of human ANKH. |
Rabbit Polyclonal antibody to UGT1A9 (UDP glucuronosyltransferase 1 family, polypeptide A9)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 291 and 530 of UGT1A9 (Uniprot ID#O60656) |
Rabbit Polyclonal antibody to RAMP2 (receptor (G protein-coupled) activity modifying protein 2)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region within amino acids 111 and 175 of RAMP2 (Uniprot ID#O60895) |
Active filters
Reactivities
- Rat
Applications
- WB
Clonalities
- Polyclonal
Families
- Transmembrane
Availabilities
- In Stock
Filter by
Category
Target Symbol
- EGFR (18)
- FGFR1 (9)
- GRIN2B (9)
- MET (9)
- ERBB2 (8)
- PDGFRB (8)
- BCL2L1 (6)
- GJA1 (6)
- IGF1R (6)
- APP (5)
- NGFR (5)
- STX1A (5)
- SYT1 (5)
- BAX (4)
- CANX (4)
- CLDN1 (4)
- CLDN7 (4)
- CSF1R (4)
- GLRA1 (4)
- INSR (4)
- NOTCH2 (4)
- PTPRC (4)
- ACE (3)
- CA14 (3)
- CASR (3)
- CAV1 (3)
- CSF2RA (3)
- EPHA3 (3)
- F10 (3)
- GRIK1 (3)
- GRM3 (3)
- HAVCR1 (3)
- ITGB3 (3)
- KCNA5 (3)
- LPAR4 (3)
- NTRK2 (3)
- RET (3)
- SPAG4 (3)
- ABCB6 (2)
- ABCD4 (2)
- ACVR2A (2)
- ADAM17 (2)
- ADRA1A (2)
- AGTR1 (2)
- AIFM1 (2)
- ALDH6A1 (2)
- ANTXR1 (2)
- APLP1 (2)
- APLP2 (2)
- AQP1 (2)
- ARMCX3 (2)
- AUP1 (2)
- BAK1 (2)
- BCL2 (2)
- BNIP1 (2)
- BSG (2)
- CA4 (2)
- CADM4 (2)
- CAV3 (2)
- CCR3 (2)
- CD19 (2)
- CD44 (2)
- CD63 (2)
- CDH1 (2)
- CDH3 (2)
- CERS2 (2)
- CFTR (2)
- CHRM1 (2)
- CLDN11 (2)
- CRHR2 (2)
- CX3CR1 (2)
- CYB5A (2)
- CYP3A4 (2)
- DGAT1 (2)
- DIABLO (2)
- EDA (2)
- EFNB1 (2)
- FZD4 (2)
- FZD8 (2)
- GABRB1 (2)
- GHSR (2)
- GPM6A (2)
- GRIN1 (2)
- GRM7 (2)
- GRM8 (2)
- GRPR (2)
- HTR4 (2)
- IL11RA (2)
- ITGB1 (2)
- KCNA1 (2)
- KCNC1 (2)
- KCNMB2 (2)
- KDR (2)
- LAT (2)
- LYVE1 (2)
- MCL1 (2)
- MME (2)
- NPHS1 (2)
- OPRL1 (2)
- P2RY2 (2)
Antibody Hosts
Conjugates
Modifications
Pathways
- Neuroactive ligand-receptor interaction (114)
- Pathways in cancer (106)
- Cytokine-cytokine receptor interaction (92)
- Calcium signaling pathway (71)
- Focal adhesion (68)
- Adherens junction (59)
- Colorectal cancer (58)
- Endocytosis (55)
- Melanoma (55)
- Prostate cancer (54)
- Regulation of actin cytoskeleton (52)
- MAPK signaling pathway (48)
- Metabolic pathways (44)
- Gap junction (39)
- Cell adhesion molecules (CAMs) (38)
- Glioma (35)
- Pancreatic cancer (35)
- Alzheimer's disease (33)
- Bladder cancer (30)
- Hematopoietic cell lineage (30)
- Endometrial cancer (29)
- Epithelial cell signaling in Helicobacter pylori infection (29)
- ErbB signaling pathway (29)
- Amyotrophic lateral sclerosis (ALS) (27)
- Axon guidance (27)
- Non-small cell lung cancer (27)
- Huntington's disease (23)
- Dorso-ventral axis formation (22)
- GnRH signaling pathway (21)
- Leukocyte transendothelial migration (21)
- Apoptosis (18)
- Neurotrophin signaling pathway (18)
- ABC transporters (17)
- Melanogenesis (17)
- Jak-STAT signaling pathway (15)
- SNARE interactions in vesicular transport (15)
- Tight junction (15)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (14)
- Long-term potentiation (14)
- Wnt signaling pathway (14)
- Hypertrophic cardiomyopathy (HCM) (13)
- Systemic lupus erythematosus (13)
- Vascular smooth muscle contraction (13)
- Basal cell carcinoma (12)
- Renal cell carcinoma (12)
- Dilated cardiomyopathy (11)
- ECM-receptor interaction (10)
- Small cell lung cancer (10)
- Chemokine signaling pathway (9)
- Notch signaling pathway (9)
- Pathogenic Escherichia coli infection (9)
- Primary immunodeficiency (9)
- Renin-angiotensin system (9)
- Chronic myeloid leukemia (8)
- Fc gamma R-mediated phagocytosis (8)
- Long-term depression (8)
- Retinol metabolism (8)
- T cell receptor signaling pathway (8)
- TGF-beta signaling pathway (8)
- Antigen processing and presentation (7)
- Oocyte meiosis (7)
- Parkinson's disease (7)
- Progesterone-mediated oocyte maturation (7)
- Adipocytokine signaling pathway (6)
- Insulin signaling pathway (6)
- Lysosome (6)
- Natural killer cell mediated cytotoxicity (6)
- Thyroid cancer (6)
- Type II diabetes mellitus (6)
- Viral myocarditis (6)
- p53 signaling pathway (6)
- Arachidonic acid metabolism (5)
- Hedgehog signaling pathway (5)
- Metabolism of xenobiotics by cytochrome P450 (5)
- N-Glycan biosynthesis (5)
- Nitrogen metabolism (5)
- Oxidative phosphorylation (5)
- Prion diseases (5)
- Toll-like receptor signaling pathway (5)
- Vibrio cholerae infection (5)
- Cardiac muscle contraction (4)
- Complement and coagulation cascades (4)
- Drug metabolism - cytochrome P450 (4)
- Glycerolipid metabolism (4)
- Glycerophospholipid metabolism (4)
- Acute myeloid leukemia (3)
- Androgen and estrogen metabolism (3)
- Drug metabolism - other enzymes (3)
- Fc epsilon RI signaling pathway (3)
- Glycosphingolipid biosynthesis - ganglio series (3)
- Linoleic acid metabolism (3)
- Purine metabolism (3)
- Riboflavin metabolism (3)
- Allograft rejection (2)
- Asthma (2)
- B cell receptor signaling pathway (2)
- Biosynthesis of unsaturated fatty acids (2)
- Cell cycle (2)
- Cyanoamino acid metabolism (2)
- Fatty acid metabolism (2)
- Glutathione metabolism (2)
- Glycosphingolipid biosynthesis - lacto and neolacto series (2)
- Graft-versus-host disease (2)
- Inositol phosphate metabolism (2)
- Keratan sulfate biosynthesis (2)
- Olfactory transduction (2)
- PPAR signaling pathway (2)
- Porphyrin and chlorophyll metabolism (2)
- Propanoate metabolism (2)
- Pyrimidine metabolism (2)
- Selenoamino acid metabolism (2)
- Sphingolipid metabolism (2)
- Steroid biosynthesis (2)
- Taste transduction (2)
- Taurine and hypotaurine metabolism (2)
- Tryptophan metabolism (2)
- Tyrosine metabolism (2)
- VEGF signaling pathway (2)
- Valine (2)
- leucine and isoleucine degradation (2)
- Amino sugar and nucleotide sugar metabolism (1)
- Ascorbate and aldarate metabolism (1)
- Autoimmune thyroid disease (1)
- C21-Steroid hormone metabolism (1)
- Ether lipid metabolism (1)
- Glycosphingolipid biosynthesis - globo series (1)
- Heparan sulfate biosynthesis (1)
- NOD-like receptor signaling pathway (1)
- Nicotinate and nicotinamide metabolism (1)
- O-Glycan biosynthesis (1)
- Pentose and glucuronate interconversions (1)
- Phosphatidylinositol signaling system (1)
- Primary bile acid biosynthesis (1)
- RIG-I-like receptor signaling pathway (1)
- Starch and sucrose metabolism (1)
- Terpenoid backbone biosynthesis (1)
- Type I diabetes mellitus (1)
- Ubiquitin mediated proteolysis (1)